Research And Development

OUR PURPOSE

Enriching Lives—that's not only our prime priority; it is our only priority! Making a difference in our patients' lives is our unwavering commitment. To ensure this, our core strategy is to find the best collaborative solution for the development of each product.

At MyGenic, we work persistently towards the production of top-quality generic products, branded generics, specialty products, active pharmaceutical ingredients, and nutraceuticals, which are marketed in India as well as globally.

mygenic r&d
mygenic r&d

RESEARCH FACILITIES

Our team of researchers includes over 500 competent individuals stationed at six different R&D centers located in India and the USA. Together, they contribute to our enviable expertise in developing generics, transdermal drug delivery systems, oral films, difficult-to-produce technology-intensive products, and Novel Drug Delivery Systems (NDDS). We have dedicated teams for process development and packaging development.

Our research strategy and implementation are strongly supported by our proficient Intellectual Property (IP) team, which possesses extensive expertise and rich experience in chemistry, analytical techniques, dosage forms, and global patent law. Over the last decade, we have consistently challenged patents on several high-value products in the US under the First-to-File exclusivity provision of the Hatch-Waxman Act. This enables us to provide high-quality generic versions of such products at reasonable costs. Our IP team continuously strives to capture new developments across the company and protect them as intellectual property.

Furthermore, our R&D centers have been audited and approved by international regulatory authorities, including the US FDA, European, Australian, and other relevant authorities.

ACHIEVEMENTS

Our R&D Centre has developed products and filed over 150 ANDAs with the USA FDA, nearly 70 products with TGA Australia, approximately 40 products for the EU, and numerous dossiers in other countries including Brazil, South Africa, Canada, Chile, and the rest of the world. Our research capabilities have not only resulted in business success but have also earned us an enviable reputation for quality and capability.

mygenic award